Home
Kimia Biosciences Ltd Share Price History
Kimia Biosciences Ltd
BSE : 08 May, 2025
39.991.7 (4.4%)
Prev Close
38.3
Open Price
40.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
63
Today's High / Low
40.0 / 40.0
52 WK High / Low
58.4 / 35.1
Market Price of Kimia Biosciences Ltd
1M
1Y
3Y
5Y
Monitoring Kimia Biosciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 1 |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Net Profit (Cr.) | -1 |
| BVPS | -6.25 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 0 |
| Op. Profit Mgn % | -15.75 |
| Net Profit Mgn % | -52.74 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Kimia Biosciences Ltd
- Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal.
- The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana.
- The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
- It came out with a public issue in Feb.'95 to part-finance the project.
- Commercial production commenced in May '95. During the 1998-99, the company has become a sick industrial units. The Hon'ble BIFR vide order dated 27th December, 2005 had deregistered the Company as Sick Industrial Undertaking on the ground that 100% of the capacity was utilized for manufacture of the intermediate products for M/s Ranbaxy Laboratoty Limfted (RLL) and , thereby, turning-out to be an ancillary industrial Undertaking.
Popular Search
FAQs for Kimia Biosciences Ltd Share Price History
What are the key events that typically impact Kimia Biosciences Ltd's share price history?
Key events that impact Kimia Biosciences Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Kimia Biosciences Ltd's share price history?
Stock splits reduce the nominal price of Kimia Biosciences Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Kimia Biosciences Ltd?
Dividends can influence Kimia Biosciences Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Kimia Biosciences Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Kimia Biosciences Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Kimia Biosciences Ltd’s share price history?
To understand Kimia Biosciences Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
